Clinical trials
COVID-19 clinical trials
Below are recruiting covid-19 clinical trials, each written for real people, not researchers. We’re tracking 305 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07651761Enrolling by invitation
Vaccine Talk Training for Primary Care Doctors
This study tests whether special training helps primary care doctors have better conversations with patients about flu and COVID-19 vaccines. You may be eligible if you're a patient who visits a participating clinic during the 2026–2027 vaccine season.
Worcester, MassachusettsAges 18 years+ - NCT07529197Recruiting
Study of Immunoadsorption Treatment for Post-Infectious ME/CFS
This study observes how a blood-cleaning treatment called immunoadsorption works in patients with ME/CFS (severe fatigue condition) who have specific immune markers. Researchers will track whether this treatment helps reduce symptoms and improve daily functioning.
Berlin, State of BerlinAges 18–65 - NCT07597876Recruiting
COVID-19 Patient Registry and Data Collection Study
This study collects medical information from COVID-19 patients to help doctors better understand the disease and improve treatment. You'll be asked about your health history and how COVID-19 has affected you.
PaviaAges Any age - NCT06695364Enrolling by invitation
Opinions on distance medicine education during COVID-19
This study asks medical students about their views on distance learning during the pandemic. It aims to understand how remote education worked for future doctors.
TekirdağAges 18–45 - NCT06547762Enrolling by invitation
Hybrid rehab for kids with physical disabilities
This trial tests a hybrid approach to rehabilitation for children with physical disabilities, combining in-person and technology-based care. If your child gets outpatient therapy more than once a week and can follow instructions with your help using a computer, this might be a good fit.
JerusalemAges 3–21 - NCT06513871Enrolling by invitation
Social perception study for ages 16 and up
This study looks at how people understand social situations. It may help us learn more about social thinking in everyday life.
New Haven, ConnecticutAges 16–65 - NCT06513858Enrolling by invitation
Community drum circle for wellness
This study looks at how a community drum circle may affect your wellbeing. It is open to anyone aged 16 and older.
New Haven, ConnecticutAges 16–65 - NCT06513845Enrolling by invitation
Drum circle study for adults
This study is looking at how drumming together in a group may affect people's sense of connection and well-being. You may be able to join if you are 18 or older.
New Haven, ConnecticutAges 18–65 - NCT06503939Enrolling by invitation
Treating long COVID cough with inhaled steroids
This trial is testing if inhaled steroid medications (ICS or ICS/LABA) can help people whose cough continues long after a COVID-19 infection. It is designed for adults whose cough started after a positive COVID test and has lasted more than 8 weeks without other lung issues.
Changsha, HunanAges 18 years+ - NCT06095284Enrolling by invitation
Antiseizure drug use in nursing homes before and after COVID-19
This study looks at how antiseizure medications are prescribed to long-term nursing home residents and how those prescriptions changed during the COVID-19 pandemic. It helps understand if prescribing patterns affected residents' health.
Richmond, VirginiaAges 21 years+ - NCT05787418Enrolling by invitationPhase 3
Nasal spray to prevent COVID-19 after a close exposure
This Phase 3 trial tests whether a medicated nasal spray can stop COVID-19 from starting after you’ve been exposed to someone who recently tested positive. You must start very soon after the person became symptomatic, and you’ll be checked for eligibility based on timing and your health history.
BeijingAges 12–85 - NCT05769023Enrolling by invitation
Pilot test targeting HIV prevention for people who inject drugs
This pilot program studies where HIV risk is highest and uses that information to decide how prevention efforts should be delivered. If you’ve used opioids recently and you inject drugs, you may be invited to participate to help reduce HIV risk.
Baltimore, MarylandAges 18 years+ - NCT05610423Enrolling by invitation
Study of heart inflammation after COVID-19 vaccination in Norway
This study looks at people who may have developed myocarditis or pericarditis (inflammation of the heart muscle or the lining around the heart) shortly after a COVID-19 vaccine. It compares their health records to vaccination records to understand who is affected and when, which may help improve future care.
OsloAges 5 years+ - NCT05589376Enrolling by invitation
Healthy people registry study for you and me
This study sets up a registry of healthy people who can answer surveys and assessments. It helps researchers understand health and how people feel over time, even if you’re not being treated for a specific illness.
Merced, CaliforniaAges 2 years+ - NCT05269277Enrolling by invitation
Study ways to help nurses stay working during COVID-19
This study looks at what hospital teams can do to help nurses stay in their jobs during the ongoing COVID-19 period. It will gather information from nurses and adult hospital staff to better understand what helps and what makes work harder.
Loveland, ColoradoAges Any age - NCT04363047Enrolling by invitation
Study of immune cells in people linked to COVID-19
This study looks at immune (infection-fighting) cells in people who have previously joined certain healthy volunteer research groups. It may help researchers better understand how the immune system responds to coronavirus infections, including COVID-19.
Manchester, Greater ManchesterAges 18 years+ - NCT04326426Enrolling by invitationPhase 3
Study of tradipitant for severe or critical COVID-19
This trial tests whether tradipitant can improve outcomes for adults with severe or critical COVID-19, including pneumonia and low oxygen. It may help patients whose lungs are significantly affected and who need careful hospital-level care.
New York, New YorkAges 18–90
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for covid-19?
- Yes. Clin2 currently lists 305 recruiting covid-19 studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a covid-19 trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a covid-19 trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.